About Us

About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Radioimmunoassay Market Research, Diagnostic Applications & Forecasts Report 2025-2033 | Rising Research in Endocrinology, Oncology, and Infectious Diseases Fuels Global Growth - ResearchAndMarkets.com

By: via Business Wire

The "Radioimmunoassay Market - Diagnostic Applications & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering.

Global Radioimmunoassay Market size is anticipated to grow from US$ 710 Million in 2024 to US$ 1.12 billion in 2033 at a CAGR of 5.21%

Increased research activities in endocrinology, oncology, and infectious disease diagnosis, and more extensive application of RIA in both developed and emerging countries, are some other factors driving the growth of the market.

RIA has transformed medical diagnosis from its inception in the 1960s, particularly in endocrinology, where it permitted accurate quantitation of hormones including insulin, thyroid hormones, and cortisol. Even though it has been increasingly displaced by non-radioactive counterparts such as ELISA on account of safety and handling issues, RIA is still widely used in certain clinical and research applications on account of its high sensitivity and specificity. It remains to be extensively applied in specialized laboratories for detecting drugs, hormones, and even tumor markers, keeping its use relevant in medical and pharmaceutical research.

Growth Drivers in the Radioimmunoassay Market

Increased Demand for Early and Precise Diagnosis of Diseases

The growing incidence of infectious and chronic conditions has boosted the demand for precise diagnostic products. Radioimmunoassay (RIA) is extremely useful in the detection of low doses of drugs, hormones, and antigens, and is therefore crucial in the diagnosis of thyroid conditions, certain malignancies, and endocrine disorders. As medical systems are prioritizing preventive therapy, RIA is becoming more commonly utilized by hospitals and clinical laboratories to enhance the health outcomes of patients by facilitating faster diagnosis.

Technological Improvement in RIA Kits and Automation

Technology is the key driving force in the radioimmunoassay market. New-generation RIA kits are more user-friendly, precise, and automated, which minimizes human error and maximizes workflow efficiency. Technological advancements, for example, robotic liquid handling systems, enable high-throughput testing with reduced human intervention. Such enhancements make RIA accessible to more labs, including those in constrained environments.

Additionally, advancements in radioisotope safety and handling procedures are making the technology safer and more environmentally friendly, which spurs increased use in both industrialized and developing healthcare systems. Another key driver of the growth of the radioimmunoassay market is the very high sensitivity and specificity of RIA methods in contrast to most other immunoassays.

Growing Applications in Pharmaceutical and Biomedical Research

RIA is an important component in drug development, pharmacokinetics, and clinical trials. Pharmaceutical firms apply it to quantify drug levels and biological effects for the assurance of efficacy and safety. Its sensitivity enables scientists to track low-dose responses and perform thorough biomarker studies.

With heightened investment in life science research, especially in the developing countries, demand for RIA in academic and commercial R&D is on the increase. Moreover, growth of personalized medicine and targeted therapies has amplified the requirement of accurate biomolecular measurement tools, further fueling RIA use in clinical as well as non-clinical research settings.

Challenges in the Radioimmunoassay Market

Strict Regulatory Controls and Radioactive Waste Management

One of the main hurdles for the RIA market is regulatory concern over the application and disposal of radioactive sources. Because of the inherent danger of radioisotopes, laboratories are required to meet stringent safety requirements and environmental regulations, which can be time-consuming and expensive. Overregulation could hold up product approvals or restrict use in some areas.

Additionally, appropriate radioactive waste disposal involves trained staff and dedicated facilities, which might not be present in every healthcare or research environment. Such challenges will discourage new entrants and restrict the growth of RIA technologies within less-developed economies.

Competition from Non-Radioactive Alternatives

The availability of non-radioactive immunoassay methods like ELISA (enzyme-linked immunosorbent assay) and chemiluminescent immunoassays threatens the RIA market extensively. These alternatives provide comparable sensitivity without the hassles of radioactive handling, storage, or waste disposal.

With improving technology, these newer techniques are becoming more cost-efficient, gaining general acceptance, and easier to utilize in clinical practice. Laboratories and hospitals tend to favor non-radioactive techniques because of their lower risk for safety and easier compliance. This transition in preference is increasingly diminishing demand for conventional RIA, particularly in countries with harsh regulatory regimes.

Key Players Analysis: Overview, Key Persons, Product Analysis, Recent Developments, Revenue

  • Danaher (Beckman Coulter, Inc.)
  • Berthold Technologies GmbH & Co. KG
  • DIAsource ImmunoAssays SA
  • BioCheck, Inc. (DRG International Inc.)
  • IBL International
  • Merck KGaA
  • Abbexa
  • Institute of Isotopes Co. Ltd.
  • Marin Biologic Laboratories, Inc.
  • Demeditec Diagnostics GmbH

Key Attributes:

Report Attribute Details
No. of Pages 200
Forecast Period 2024 - 2033
Estimated Market Value (USD) in 2024 $710 Million
Forecasted Market Value (USD) by 2033 $1120 Million
Compound Annual Growth Rate 5.2%
Regions Covered Global 

Key Topics Covered:

1. Introduction

2. Research & Methodology

2.1 Data Source

2.1.1 Primary Sources

2.1.2 Secondary Sources

2.2 Research Approach

2.2.1 Top-Down Approach

2.2.2 Bottom-Up Approach

2.3 Forecast Projection Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers

4.2 Challenges

5. Global Radioimmunoassay Market

5.1 Historical Market Trends

5.2 Market Forecast

6. Market Share Analysis

6.1 By Product

6.2 By Application

6.3 By End User

6.4 By Countries

7. Product

7.1 Analyzers

7.2 Reagents and Kits

8. Application

8.1 Research

8.2 Clinical Diagnostics

9. End User

9.1 Hospitals

9.2 Clinical Diagnostic Laboratories

9.3 Pharmaceutical Industries

9.4 Other End Users

10. Countries

10.1 North America

10.2 Europe

10.3 Asia Pacific

10.4 Latin America

10.5 Middle East & Africa

11. Value Chain Analysis

12. Porter's Five Forces Analysis

12.1 Bargaining Power of Buyers

12.2 Bargaining Power of Suppliers

12.3 Degree of Competition

12.4 Threat of New Entrants

12.5 Threat of Substitutes

13. SWOT Analysis

13.1 Strength

13.2 Weakness

13.3 Opportunity

13.4 Threats

14. Pricing Benchmark Analysis

14.1 Danaher (Beckman Coulter, Inc.)

14.2 Berthold Technologies GmbH & Co. KG

14.3 DIAsource ImmunoAssays SA

14.4 BioCheck, Inc. (DRG International Inc.)

14.5 IBL International

14.6 Merck KGaA

14.7 Abbexa

14.8 Institute of Isotopes Co. Ltd.

14.9 Marin Biologic Laboratories, Inc.

14.10 Demeditec Diagnostics GmbH

15. Key Players Analysis

For more information about this report visit https://www.researchandmarkets.com/r/sj94th

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com



For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

More News

View More
Caterpillar Stock Hits All-Time High—Is There More Room to Run?
Via MarketBeat
Topics Artificial Intelligence Economy World Trade
Tickers CAT
Berkshire-Backed Lennar Slides After Weak Q3 Earnings
Via MarketBeat
Topics ETFs
Tickers BRK-A BRK-B LEN
Analysts Turn Bullish on Hershey—Is Pepsi the Next Value Play?
Via MarketBeat
Tickers GS HSY PEP
Coming in Hot: Retail Data Drives Momentum in 3 E-Commerce Stocks
Via MarketBeat
Topics Economy
Tickers AMZN ETSY SHOP
MarketBeat Week in Review – 09/15 - 09/19
Via MarketBeat
Topics Economy
Tickers AAPL AMZN AVGO BE CRWD JOBY
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.